Home
Loading

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

aVenture is in Alpha: During this preview period, you should expect the research data to be limited and may not yet meet our exacting standards. We've made the decision to provide early access to our data to showcase the product as we build, but you should not yet rely upon it alone for your investment decisions.

Get in touch

  • Contact

  • Request a demo

  • Request data updates

  • Add a company

Research

  • Companies

  • Investors

  • People

aVenture

  • Sitemap

  • Feature requests

Member

Backed by

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy Policy

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading homepage
Loading
Home›Research›Companies

Companies

Loading
Home›
Research›
Companies›
Aarden Pharmaceuticals
AddedFeb 19, 2024
UpdatedJun 18, 2026
Aarden Pharmaceuticals

Aarden Pharmaceuticals

Aarden Pharmaceuticals pioneers in small molecule drug discovery, targeting un-druggable intracellular diseases.

HQ
Indianapolis, IN, US
Founded
2008
Overview
Compare
Fundraising
Employees

Aarden Pharmaceuticals is dedicated to small molecule drug discovery and development, focusing on previously un-druggable intracellular phosphatase (PTP) disease targets. Leveraging novel chemistry technology developed by Dr. Zhong-Yin Zhang at Indiana University School of Medicine, the company aims to revolutionize treatment options for challenging diseases.

Aarden Pharmaceuticals has made significant strides in the biotech industry, driven by Dr. Zhang's expertise and leadership. The company's innovative approach has the potential to transform therapeutic strategies, addressing unmet medical needs and advancing the field of drug discovery.

Aarden Pharmaceuticals - Similar Companies

Aria Pharmaceuticals logo

Aria Pharmaceuticals

Adrx logo

Adrx

adrxpharma.com

Alcinous Pharmaceuticals logo

Alcinous Pharmaceuticals

Generian Pharmaceuticals logo

Generian Pharmaceuticals

generian.com

Arrien Pharmaceuticals logo

Arrien Pharmaceuticals

arrienpharma.com

Azevan Pharmaceuticals logo

Azevan Pharmaceuticals

azevan.com

Caden Biosciences logo

Caden Biosciences

Advenchen Laboratories logo

Advenchen Laboratories

advenchen.com

Design Pharmaceuticals logo

Design Pharmaceuticals

Pinpoint Pharma logo

Pinpoint Pharma

pinpointpharma.co

Ensemble Discovery logo

Ensemble Discovery

Akanocure Pharmaceuticals logo

Akanocure Pharmaceuticals

akanocure.com

Aquinnah Pharmaceuticals logo

Aquinnah Pharmaceuticals

aquinnahpharma.com

Promiliad Biopharma logo

Promiliad Biopharma

BridGene Biosciences logo

BridGene Biosciences

Aarden Pharmaceuticals - Quick Facts

Who are Aarden Pharmaceuticals' competitors?

Companies similar to Aarden Pharmaceuticals include Aria Pharmaceuticals, Adrx, Alcinous Pharmaceuticals and Generian Pharmaceuticals.

When was Aarden Pharmaceuticals founded?

Aarden Pharmaceuticals was founded in 2008.

Where is Aarden Pharmaceuticals' headquarters located?

Aarden Pharmaceuticals' headquarters is located in Indianapolis, IN, US.

When was Aarden Pharmaceuticals' last funding round?

Aarden Pharmaceuticals' most recent funding round was for $500k (USD) in January 2011.

How much has Aarden Pharmaceuticals raised to-date?

As of Jan 3, 2011, Aarden Pharmaceuticals has raised a total of $500k (USD).

How many employees does Aarden Pharmaceuticals have?

Aarden Pharmaceuticals has 5 employees as of Feb 5, 2024.

Aarden Pharmaceuticals - Classification

Ownership
  • Venture Capital
Technology
  • Biotech
Geographic Exposure
  • United States
Revenue
  • Recurring
  • Software
Customer
  • Enterprise
Main Product
  • Drug Discovery
Tags
  • Pharmaceuticals
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541714Research and Development in Biotechnology (except Nanobiotechnology)
  • 541000Professional, Scientific, and Technical Services
  • 541700Scientific Research and Development Services
  • 541710Research and Development in the Physical, Engineering, and Life Sciences
SIC
  • 8700Engineering, Accounting, Research, Management, And Related Services
  • 8730Research, Development, And Testing Services
  • 8731Commercial Physical and Biological Research
Show 12 more industry codes
NAICS
  • 320000Manufacturing
  • 325400Pharmaceutical and Medicine Manufacturing
  • 620000Health Care and Social Assistance
  • 325000Chemical Manufacturing
  • 325410Pharmaceutical and Medicine Manufacturing
  • 325412Pharmaceutical Preparation Manufacturing
SIC
  • 2800Chemicals And Allied Products
  • 8000Health Services
  • 2830Drugs
  • 8040Offices And Clinics Of Other Health Practitioners
  • 2834Pharmaceutical Preparations
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified